VistaGen Therapeutics Overview
Founded
1998
Status
Public
Employees
9
Stock Symbol
VTGN
Investments
1
Share Price
$0.45
(As of Thursday Closing)
VistaGen Therapeutics General Information
Description
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
- 343 Allerton Avenue
- South San Francisco, CA 94080
- United States
+1 (650) 000-0000
VistaGen Therapeutics Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.45 | $0.45 | $0.29 - $1.49 | $22.5M | 49.9M | 620K | -$0.58 |
VistaGen Therapeutics Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2019 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 | FY 2017 31-Mar-2017 |
|---|---|---|---|---|
| EV | 30,079 | 46,412 | 8,280 | 12,489 |
| Revenue | 0 | 0 | 0 | 1,250 |
| EBITDA | (23,156) | (24,488) | (14,254) | (10,194) |
| Net Income | (23,231) | (24,590) | (14,346) | (10,256) |
| Total Assets | 5,331 | 14,012 | 11,278 | 3,712 |
| Total Debt | 4,177 | 67 | 66 | 69 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
VistaGen Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore VistaGen Therapeutics‘s full profile, request access.
Request a free trial
VistaGen Therapeutics Executive Team (8)
VistaGen Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000000 00.0 | VistaGen Therapeutics | Director | 000 0000 |
| 0. 000000000 | VistaGen Therapeutics | Chief Scientific Officer & Board Member | 000 0000 |
| 0000 0000 00 | Self | Chairman | 000 0000 |
| 00000 00000 00 | VistaGen Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
VistaGen Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 00000000 | 11-May-2011 | 000000000000000000 | Other Consumer Products and Services | 00000 00000 00 |
Ready to get started?
Request a free trial